Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Lupin Limited
Press Release Jan 16 2023
Business
Jan 16 2023
3 min read

Press Release Jan 16 2023

Lupin Limited has informed the Exchange regarding a press release dated January 16, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir and RilpivirineTablets.".

View Attachment